- Professor, Tel Aviv University
Cell Research and Immunology
Dr. Vered Padler-Karavani is a Professor in the Shmunis School of Biomedicine and Cancer Research at the George S. Wise Faculty of Life Sciences, Tel Aviv University. She earned her BSc in Biology, MSc in Biochemistry, and PhD in Biochemistry — all magna cum laude — from Tel Aviv University, and completed postdoctoral training in glycobiology at the University of California, San Diego, before joining Tel Aviv University in 2013.
Dr. Padler-Karavani’s research focuses on glycan immune recognition and response, integrating glycobiology, immunology, biotechnology, bioinformatics, xenotransplantation, and cancer research. Her laboratory develops novel diagnostics and therapeutics for chronic inflammation-related diseases including cancer, autoimmunity, and allergy, employing cutting-edge technologies such as glycan microarrays, glyco-nanotechnology, CAR-T immunotherapy, and AI-based bioinformatics. For the Colton Consortium, her group is investigating the role of glycosylation in inflammatory bowel disease.
She is a recipient of multiple European Research Council (ERC) grants and the ISEF Award for Research Excellence and Social Leadership, and currently serves as Treasurer and Vice President of the Israel Immunological Society. She has authored over 60 peer-reviewed publications.
